Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Minority Interest (2016)

United Therapeutics' Minority Interest history spans 8 years, with the latest figure at $10.9 million for Q4 2016.

  • On a quarterly basis, Minority Interest changed 0.0% to $10.9 million in Q4 2016 year-over-year; TTM through Dec 2016 was $10.9 million, a 0.0% change, with the full-year FY2016 number at $10.9 million, changed 0.0% from a year prior.
  • Minority Interest hit $10.9 million in Q4 2016 for United Therapeutics, roughly flat from $10.9 million in the prior quarter.
  • Over the last five years, Minority Interest for UTHR hit a ceiling of $10.9 million in Q4 2015 and a floor of $10.9 million in Q1 2012.
  • Historically, Minority Interest has averaged $10.9 million across 5 years, with a median of $10.9 million in 2012.
  • Biggest five-year swings in Minority Interest: changed 0.0% in 2012 and later grew 0.17% in 2015.
  • Tracing UTHR's Minority Interest over 5 years: stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then rose by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
  • Business Quant data shows Minority Interest for UTHR at $10.9 million in Q4 2016, $10.9 million in Q4 2015, and $10.9 million in Q3 2015.